Streptococcus suis in humans, Thailand [4]

Emerging Infectious Diseases

Volumn 14, Issue 1, 2008, Pages 181-183

  Takamatsu, Daisuke ^a   Wongsawan, Korawan ^b   Osaki, Makoto ^a   Nishino, Hiroto ^c   Ishiji, Tomono ^d   Tharavichitkul, Prasit ^b   Khantawa, Banyong ^b   Fongcom, Achara ^e   Takai, Shinji ^f   Sekizaki, Tsutomu ^a,g  

^a NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c Northern District Livestock Health and Hygiene Office   (Japan)

^d Seibu Livestock Hygiene Service Center   (Japan)

^e Lamphun Hospital   (Thailand)

^f KITASATO UNIVERSITY   (Japan)

^g GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EXTRACELLULAR FACTOR; MURAMIDASE RELEASED PROTEIN; POLYSACCHARIDE; SUILYSIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; HUMAN; LETTER; NONHUMAN; POLYMERASE CHAIN REACTION; POLYSACCHARIDE CAPSULE; SEROTYPE; SEROTYPING; STREPTOCOCCUS SUIS; ZOONOSIS;

EID: 38049028546     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1401.070568     Document Type: Letter

References (10)

1. Staats JJ, Feder I, Okwumabua O, Chengappa MM. Streptococcus suis: past and present. Vet Res Commun. 1997;21:381-407.
2. Vecht U, Wisselink HJ, van Dijk JE, Smith HE. Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect Immun. 1992;60:550-6.
3. Jacobs AAC, Loeffen PLW, van den Berg AJG, Storm PK. Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect Immun. 1994;62:1742-8.
4. Smith HE, Damman M, van der Velde J, Wagenaar F, Wisselink HJ, Stockhofe-Zurwieden N, et al. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect Immun. 1999;67:1750-6.
5. Vecht U, Wisselink HJ, Jellema ML, Smith HE. Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect Immun. 1991;59:3156-62.
6. Gottschalk M, Lebrun A, Wisselink H, Dubreuil JD, Smith H, Vecht U. Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can J Vet Res. 1998;62:75-9.
7. King SJ, Leigh JA, Heath PJ, Luque I, Tarradas C, Dowson CG, et al. Development of a multilocus sequence typing scheme for the pig pathogen Streptococcus suis: identification of virulent clones and potential capsular serotype exchange. J Clin Microbiol. 2002;40:3671-80.
8. Chang B, Wada A, Ikebe T, Ohnishi M, Mita K, Endo M, et al. Characteritics of Streptococcus suis isolated from patients in Japan. Jpn J Infect Dis. 2006;59:397-9.
9. Ye C, Zhu X, Jing H, Du H, Segura M, Zheng H, et al. Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis. 2006;12:1203-8.
10. Silva LMG, Baums CG, Rehm T, Wisselink HJ, Goethe R, Valentin-Weigand P. Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Vet Microbiol. 2006;115:117-27.